224775-70-6

Upstream product

• 10472-97-6 8-phenyloctan-1-ol 
• 75-36-5 acetyl chloride 

Downstream Products

• 1094765-49-7 3-(4-chlorophenyl)-2-(4-(8-azidooctylphenyl)thiazol-2-ylamino)propionic acid 
• 1094765-51-1 3-(4-chlorophenyl)-2-(4-(8-aminooctylphenyl)thiazol-2-ylamino)propionic acid 
• 1094765-46-4 2-bromo-4'-(8-azido-octyl)acetophenone 
• 1094765-44-2 C₁₆H₂₃N₃O 

Relevant academic research and scientific papers

Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite

UDP-Galactopyranose mutase (UGM or Glf), which catalyzes the interconversion of UDP-galactopyranose and UDP-galactofuranose, is implicated in the viability and virulence of multiple pathogenic microorganisms. Here we report the synthesis of high-affinity ligands for UGM homologues from Klebsiella pneumoniae and Mycobacterium tuberculosis. The potency of these compounds stems from their ability to access both the substrate binding pocket and an adjacent site.

INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE THWART MYCOBACTERIAL GROWTH

Compounds which inhibit microbial growth or attenuate the virulence of pathogen microorganisms. Compounds of the invention inhibit UDP-galactopyranose mutase (UGM) and have activity as inhibitors of microbial growth of microorganisms which contain this enzyme and particularly those microorganisms in which this enzyme is responsible for the incorporation of galactofuranose residues, particularly for uridine 5'-diphosphate (UDP) galactopyranose mutase. Compounds of the invention inhibit UDP- galactopyranose mutase (UGM) and have activity to attenuate virulence of pathogenic microorganisms, including mycobacteria.